004720.KS
PharmGen Science, Inc.
KSC · Healthcare · Drug Manufacturers - General · KR
KRW 3,140.00
−0.63%Margins
Gross margin
64.3%
EBITDA margin
4.9%
EBIT margin
2.2%
Net margin
-76.6%
FCF margin
8.5%
-95.9%
Return on equity
-72.9%
Return on assets
2.8%
Return on invested capital
0.92x
Asset turnover
KRW 17.3B
Cash from operations
KRW 913
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026